Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mahdy

Showing results (171-180 of 193) with videos related to

Pageof 20
Sort By:
Future Medicinal Chemistry|February 25, 2025
Novel triazoloquinazoline derivatives as VEGFR inhibitors: synthesis, cytotoxic evaluation and <i>in silico</i> studiesReda R Mabrouk, Hazem A Mahdy, Abdallah E Abdallah, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|July 25, 2022
Benzoxazole derivatives as new VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, <i>in silico</i> studies, and antiproliferative evaluationMohammed S Taghour, Hazem A Mahdy, Maher H Gomaa, et al.
Plos One|September 4, 2025
A novel sulfamoylphenyl-dihydro-thiadiazole derivative as a dual EGFR and carbonic anhydrase inhibitor for cancer therapyIbrahim H Eissa, Hazem Elkady, Walid E Elgammal, et al.
Molecules (Basel, Switzerland)|August 12, 2022
Modified Benzoxazole-Based VEGFR-2 Inhibitors and Apoptosis Inducers: Design, Synthesis, and Anti-Proliferative EvaluationAlaa Elwan, Abdallah E Abdallah, Hazem A Mahdy, et al.
Future Medicinal Chemistry|July 19, 2023
New theobromine derivatives inhibiting VEGFR-2: design, synthesis, antiproliferative, docking and molecular dynamics simulationsHazem A Mahdy, Hazem Elkady, Mohammed S Taghour, et al.
Poultry Science|February 5, 2023
In ovo protective effects of chicoric and rosmarinic acids against Thiacloprid-induced cytotoxicity, oxidative stress, and growth retardation on newly hatched chicksMayada R Farag, Claudia Zizzadoro, Mahmoud Alagawany, et al.
Journal of Biomolecular Structure & Dynamics|June 1, 2023
Semi-synthesized anticancer theobromine derivatives targeting VEGFR-2: <i>in silico</i> and <i>in vitro</i> evaluationsMohammed A Dahab, Hazem A Mahdy, Hazem Elkady, et al.
Bioorganic Chemistry|December 9, 2019
Design, synthesis, molecular modeling, in vivo studies and anticancer evaluation of quinazolin-4(3H)-one derivatives as potential VEGFR-2 inhibitors and apoptosis inducersHazem A Mahdy, Mohammed K Ibrahim, Ahmed M Metwaly, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|August 17, 2022
New quinoline and isatin derivatives as apoptotic VEGFR-2 inhibitors: design, synthesis, anti-proliferative activity, docking, ADMET, toxicity, and MD simulation studiesEslam B Elkaeed, Mohammed S Taghour, Hazem A Mahdy, et al.
Computational Biology and Chemistry|September 15, 2023
New thiazolidine-2,4-diones as effective anti-proliferative and anti-VEGFR-2 agents: Design, synthesis, in vitro, docking, MD simulations, DFT, ADMET, and toxicity studiesHazem Elkady, Abdelrahman A Abuelkhir, Mahmoud Rashed, et al.
Pageof 20

Showing results (171-180 of 193) with videos related to

Sort By:
Pageof 20
Future Medicinal Chemistry|February 25, 2025
Novel triazoloquinazoline derivatives as VEGFR inhibitors: synthesis, cytotoxic evaluation and <i>in silico</i> studiesReda R Mabrouk, Hazem A Mahdy, Abdallah E Abdallah, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|July 25, 2022
Benzoxazole derivatives as new VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, <i>in silico</i> studies, and antiproliferative evaluationMohammed S Taghour, Hazem A Mahdy, Maher H Gomaa, et al.
Plos One|September 4, 2025
A novel sulfamoylphenyl-dihydro-thiadiazole derivative as a dual EGFR and carbonic anhydrase inhibitor for cancer therapyIbrahim H Eissa, Hazem Elkady, Walid E Elgammal, et al.
Molecules (Basel, Switzerland)|August 12, 2022
Modified Benzoxazole-Based VEGFR-2 Inhibitors and Apoptosis Inducers: Design, Synthesis, and Anti-Proliferative EvaluationAlaa Elwan, Abdallah E Abdallah, Hazem A Mahdy, et al.
Future Medicinal Chemistry|July 19, 2023
New theobromine derivatives inhibiting VEGFR-2: design, synthesis, antiproliferative, docking and molecular dynamics simulationsHazem A Mahdy, Hazem Elkady, Mohammed S Taghour, et al.
Poultry Science|February 5, 2023
In ovo protective effects of chicoric and rosmarinic acids against Thiacloprid-induced cytotoxicity, oxidative stress, and growth retardation on newly hatched chicksMayada R Farag, Claudia Zizzadoro, Mahmoud Alagawany, et al.
Journal of Biomolecular Structure & Dynamics|June 1, 2023
Semi-synthesized anticancer theobromine derivatives targeting VEGFR-2: <i>in silico</i> and <i>in vitro</i> evaluationsMohammed A Dahab, Hazem A Mahdy, Hazem Elkady, et al.
Bioorganic Chemistry|December 9, 2019
Design, synthesis, molecular modeling, in vivo studies and anticancer evaluation of quinazolin-4(3H)-one derivatives as potential VEGFR-2 inhibitors and apoptosis inducersHazem A Mahdy, Mohammed K Ibrahim, Ahmed M Metwaly, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|August 17, 2022
New quinoline and isatin derivatives as apoptotic VEGFR-2 inhibitors: design, synthesis, anti-proliferative activity, docking, ADMET, toxicity, and MD simulation studiesEslam B Elkaeed, Mohammed S Taghour, Hazem A Mahdy, et al.
Computational Biology and Chemistry|September 15, 2023
New thiazolidine-2,4-diones as effective anti-proliferative and anti-VEGFR-2 agents: Design, synthesis, in vitro, docking, MD simulations, DFT, ADMET, and toxicity studiesHazem Elkady, Abdelrahman A Abuelkhir, Mahmoud Rashed, et al.
Pageof 20